News and Trends 1 Jun 2021
Next-Generation mRNA Vaccine Technology Unveiled in Series A Round
Messenger RNA vaccines have been at the forefront of the global struggle against the Covid-19 pandemic over the past year.…
mRNA technology
- Latest Posts
Sponsored by Merck
12 Jan 2021How the Vaccine Industry and Biotechs Can Accelerate Pandemic Responses
The global Covid-19 pandemic has forced us to put our lives on hold, and a vaccine is the most likely…
News and Trends 22 Dec 2020
EMA Greenlights BioNTech and Pfizer mRNA Vaccine for Covid-19
BioNTech and Pfizer’s Covid-19 vaccine, made from messenger RNA, has become the first of its kind to be approved by…
News and Trends 2 Apr 2020
Swiss and German Team to Develop Inhaled mRNA Coronavirus Treatment
The Swiss antibody specialist Neurimmune and the German RNA biotech Ethris are collaborating to develop inhaled messenger RNA (mRNA) antibodies…
ADVERTISEMENT
In Depth 30 Mar 2020
Could mRNA Vaccines Fulfill Their Potential Against Coronavirus?
The first vaccine against coronavirus disease could one day be made of mRNA. How is mRNA showing promise against the…
News and Trends 17 Mar 2020
CureVac Receives €80M from EU to Fund Coronavirus Vaccine Amid US Dispute
The German biotech CureVac -- which is developing an mRNA vaccine against coronavirus -- has been granted up to €80M…
News and Trends 8 Nov 2019
EU Project Receives €15M to Bring mRNA Therapy to a Wider Audience
An EU research project has launched with the aim of bringing mRNA treatments to a wider range of patients and…
Startup Scout 2 Aug 2019
This Biotech Uses Messenger RNA to Treat Lethal Lung Inflammation
Based close to Berlin, Germany, the biotech startup Pantherna Therapeutics is developing a messenger RNA drug to treat a life-threatening…
News and Trends 9 Jul 2019
BioNTech Raises Whopping €290M to Fund Personalized mRNA Vaccines for Cancer
In one of the biggest ever funding rounds in European biotech, the German company BioNTech has raised a Series B…
News and Trends 1 Mar 2019
Rapid Response mRNA Vaccine Facility Gets €30M Funding
An mRNA vaccine facility, run by the German biotech CureVac, has received a €30M development grant to rapidly manufacture vaccines…
ADVERTISEMENT
News and Trends 11 Dec 2018
What Does the Largest Biotech IPO Ever Mean for European Biotech?
With a massive €530M ($604M) raised, US-based Moderna has made a record biotech IPO. The news could give a significant…
News and Trends 16 Aug 2018
Pfizer Offers €374M for German mRNA Flu Vaccine
BioNTech, based in Mainz, Germany, has entered into a partnership with Pfizer worth up to $425M (€374M) to develop an…
News and Trends 4 Jan 2018
German Biotech Raises Record $270M Series A for Individualized Cancer Therapies
BioNTech will dedicate its huge fundraising to develop personalized cancer immunotherapies using CAR-T, TCR and mRNA technologies. BioNTech is kicking…
News and Trends 15 Nov 2017
US Biotech Unicorn Steps up Competition for BioNTech’s mRNA Personalized Cancer Vaccine
Moderna Therapeutics has started dosing patients with an mRNA-based personalized cancer vaccine that resembles another one being developed by BioNTech.…
Interview 6 Nov 2017
Battle of the Biotech Unicorns: CureVac vs. Moderna
An interview never seen before. We brought together the founders and CEOs of the two biotech unicorns pioneering mRNA therapy:…
News and Trends 2 Nov 2017
AstraZeneca and Moderna want to beat Novartis at Treating Heart Failure
AstraZeneca will work with Moderna Therapeutics to bring together to the market an mRNA version of Novartis' failed heart failure drug Serelaxin. AstraZeneca has…
ADVERTISEMENT
News and Trends 18 Oct 2017
Eli Lilly Offers German Biotech up to €1.5Bn to Develop mRNA Cancer Vaccines
CureVac will be working with pharma giant Eli Lilly in the development of up to five cancer vaccines based on…
Best in Biotech 26 Sep 2017
These Three Fields Are Proving Biotech is The Innovation Powerhouse in Healthcare
Biotech is the best source of innovation in R&D, making its companies the darlings of pharma. Which therapeutic fields belong…
News and Trends 25 Sep 2017
Belgian Biotech Gets €1M Grant to Boost its mRNA Cancer Immunotherapies
Flanders Innovation and Entrepreneurship has given eTheRNA a €1M grant to further improve its TriMix mRNA cancer therapies. eTheRNA has been…
In Depth 19 Sep 2017
RNA as a Therapy: Reviewing the Future Generation of Therapeutics
You’ve certainly heard about antibodies, peptides and even DNA as therapeutics, but what about RNA? In this review, we paint…
